Intrathecal baclofen in paroxysmal sympathetic hyperactivity: Impact on oral treatment
Brain and Behavior2018Vol. 8(11), pp. e01124–e01124
Citations Over TimeTop 19% of 2018 papers
Elke Pucks‐Faes, Gabriel Hitzenberger, Heinrich Matzak, Giulio Verrienti, Robert Schauer, Leopold Saltuari
Abstract
ITB might facilitate cutting back or dispensing with other conventional oral drugs, such as oral baclofen and oral propranolol. Our study provides further evidence that ITB treatment should be considered in patients with otherwise medically refractory PSH in severe traumatic brain injury. Further prospective multicenter studies are needed to confirm the findings of this study.
Related Papers
- → BACLOFEN (LIORESAL) IN THE LONG‐TERM MANAGEMENT OF SPASTICITY(1962)56 cited
- Intrathecal baclofen for severe spasticity: five years experience.(1991)
- Baclofen Unusual Response In Spinal Cord Injury Patients.(2019)
- [Intrathecal baclofen for severe spasticity].(2008)
- → Intrathecal baclofen infusios for treatment of spastisity.(1989)1 cited